GLIAL-CELL LINE-DERIVED NEUROTROPHIC FACTOR SUPPORTS SURVIVAL OF INJURED MIDBRAIN DOPAMINERGIC-NEURONS

被引:258
作者
BOWENKAMP, KE
HOFFMAN, AF
GERHARDT, GA
HENRY, MA
BIDDLE, PT
HOFFER, BJ
GRANHOLM, ACE
机构
[1] UNIV COLORADO, HLTH SCI CTR, SCH DENT, DEPT BASIC SCI, DENVER, CO 80262 USA
[2] UNIV COLORADO, HLTH SCI CTR, SCH MED, DEPT PSYCHOL, DENVER, CO 80262 USA
[3] UNIV COLORADO, HLTH SCI CTR, SCH MED, DEPT PSYCHIAT, DENVER, CO 80262 USA
[4] UNIV COLORADO, HLTH SCI CTR, SCH MED, NEUROSCI TRAINING PROGRAM, DENVER, CO 80262 USA
关键词
NEUROTROPHIC FACTORS; SUBSTANTIA NIGRA; PARKINSONS DISEASE; TYROSINE HYDROXYLASE; NEURONAL PLASTICITY;
D O I
10.1002/cne.903550402
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Glial cell-lined derived neurotrophic factor (GDNF) has been shown to promote survival of developing mesencephalic dopaminergic neurons in vitro. In order to determine if there is a positive effect of GDNF on injured adult midbrain dopaminergic neurons in situ, we have carried out experiments in which a single dose of GDNF was injected into the substantia nigra following a unilateral lesion of the nigrostriatal system. Rats were unilaterally lesioned by a single stereotaxic injection of 6-hydroxydopamine (6-OHDA; 9 mu g/4 mu l normal saline with 0.02% ascorbate) into the medial forebrain bundle and tested weekly for apomorphine-induced (0.05 mg/kg s.c.) contralateral rotation behavior. Rats that manifested >300 turns/hour received a nigral injection of 100 mu g GDNF, or cytochrome C as a control, 4 weeks following the 6-OHDA lesion. Rotation behavior was quantified weekly for 5 weeks after GDNF. Rats were subsequently anesthetized, transcardially perfused, and processed for tyrosine hydroxylase immunohistochemistry. It was found that 100 mu g GDNF decreased apomorphine-induced rotational behavior by more than 85%. Immunohistochemical studies revealed that tyrosine hydroxylase immunoreactivity was equally reduced in the striatum ipsilateral to the lesion in both cytochrome C and GDNF-injected animals. In contrast, large increments in tyrosine hydroxylase immunoreactivity were observed in the substantia nigra of animals treated with 100 mu g of GDNF, with a significant increase in numbers of tyrosine hydroxylase-immunoreactive cell bodies and neurites as well as a small increase in the cell body area of these neurons. The results suggest that GDNF can maintain the dopaminergic neuronal phenotype in a number of nigral neurons following a unilateral nigrostriatal lesion in the rat. (C) 1995 Wiley-Liss, Inc.
引用
收藏
页码:479 / 489
页数:11
相关论文
共 61 条
[1]   GANGLIOSIDES INCREASE THE SURVIVAL OF LESIONED NIGRAL DOPAMINE NEURONS AND FAVOR THE RECOVERY OF DOPAMINERGIC SYNAPTIC FUNCTION IN STRIATUM OF RATS BY COLLATERAL SPROUTING [J].
AGNATI, LF ;
FUXE, K ;
CALZA, L ;
BENFENATI, F ;
CAVICCHIOLI, L ;
TOFFANO, G ;
GOLDSTEIN, M .
ACTA PHYSIOLOGICA SCANDINAVICA, 1983, 119 (04) :347-363
[2]   A QUANTITATIVE STUDY ON NIGRO-NEOSTRIATAL DOPAMINE NEURON SYSTEM IN RAT [J].
ANDEN, NE ;
FUXE, K ;
HAMBERGER, B ;
HOKFELT, T .
ACTA PHYSIOLOGICA SCANDINAVICA, 1966, 67 (3-4) :306-+
[3]   EVIDENCE FOR DOPAMINE RECEPTOR STIMULATION BY APOMORPHINE [J].
ANDEN, NE ;
RUBENSON, A ;
FUXE, K ;
HOKFELT, T .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1967, 19 (09) :627-&
[4]  
ANDEN NE, 1966, ACTA PHARMACOL TOX, V24, P263
[5]  
BAETGE EE, 1994, AM SOC CELL BIOL
[6]   CHRONIC INFUSION OF NERVE GROWTH-FACTOR DOES NOT RESCUE PYRAMIDAL CELLS AFTER TRANSIENT FOREBRAIN ISCHEMIA IN THE RAT [J].
BECK, T ;
WREE, A ;
SAUER, DD .
NEUROSCIENCE LETTERS, 1992, 135 (02) :252-254
[7]   DOPAMINE IN DENDRITES OF SUBSTANTIA NIGRA NEURONS - SUGGESTIONS FOR A ROLE IN DENDRITIC TERMINALS [J].
BJORKLUND, A ;
LINDVALL, O .
BRAIN RESEARCH, 1975, 83 (03) :531-537
[8]   RECONSTRUCTION OF THE NIGROSTRIATAL DOPAMINE PATHWAY BY INTRA-CEREBRAL NIGRAL TRANSPLANTS [J].
BJORKLUND, A ;
STENEVI, U .
BRAIN RESEARCH, 1979, 177 (03) :555-560
[9]   DIFFERENTIAL EXPRESSION OF TYROSINE-HYDROXYLASE AND MEMBRANE DOPAMINE TRANSPORTER GENES IN SUBPOPULATIONS OF DOPAMINERGIC-NEURONS OF THE RAT MESENCEPHALON [J].
BLANCHARD, V ;
RAISMANVOZARI, R ;
VYAS, S ;
MICHEL, PP ;
JAVOYAGID, F ;
UHL, G ;
AGID, Y .
MOLECULAR BRAIN RESEARCH, 1994, 22 (1-4) :29-38
[10]  
BOWENKAMP KE, 1994, ABSTR SOC NEUROSCI, V20, P454